
SBRT: A viable option for treating adrenal gland metastases
Author(s) -
Edy Ippolito,
Rolando Maria D’Angelillo,
Michele Fiore,
E. Molfese,
Lucio Trodella,
Sara Ramella
Publication year - 2015
Publication title -
reports of practical oncology and radiotherapy
Language(s) - English
Resource type - Journals
eISSN - 2083-4640
pISSN - 1507-1367
DOI - 10.1016/j.rpor.2015.05.009
Subject(s) - medicine , ablative case , metastasectomy , adrenal gland , modality (human–computer interaction) , radiology , treatment modality , chemotherapy , radiation therapy , metastasis , surgery , cancer , human–computer interaction , computer science
The management strategy of adrenal metastases depends on different clinical situations. Adrenal metastasectomy in selected patients with isolated adrenal metastases is considered the treatment of choice, showing prolonged survival compared to chemotherapy alone. More recently, Stereotactic Body Radiation Therapy (SBRT) has emerged as an alternative local ablative treatment modality although limited data are available on the use of SBRT in treating adrenal gland metastases. Preliminary results are, however, encouraging, especially in selected patients with oligometastatic disease. We herewith review and discuss the potential role of SBRT as a local ablative treatment modality for adrenal metastases.